Medtronic To Distribute Viz.ai’s System For Identifying Strokes
Medtronic will distribute Viz.ai’s artificial intelligence system for detection and triage of large vessel occlusions in the US alongside Medtronic's Solitaire stent-retrievers for revascularization of occluded blood vessels in the brain.
You may also be interested in...
Happify Health raises $73m to expand digital mental health platform; Viz.ai secures $71m to extend software beyond stroke care coordination.
Device financing during 2019’s final quarter totaled $1.6bn, a substantial decrease from Q3’s $4.05bn. Merger and acquisition activity, almost doubled from the previous quarter reaching $6.1bn; Stryker’s 4.7bn takeover of Wright Medical was the only billion-dollar transaction. Financings by diagnostics/research players totaled $1.3bn (the lowest quarter of the year) and eight companies were acquired, five of which together were valued at $981m.
While US FDA works on a new guidance for clinical decision support software, the agency has OK'd the de novo application for Viz.AI Contact, a software tool to help detect early signs of strokes.